Skip to main content
. Author manuscript; available in PMC: 2014 Sep 19.
Published in final edited form as: Treat Strategies Diabetes. 2011;3(1):34–40.

Table 1.

Baseline characteristics of 500 mcg and 1000 mcg arms (mean ± SD unless noted).

Variable Groups A and B 500 mcg (n=30) Groups C and D 1000 mcg (n=29) p-value

Gender
Male 11 (36.7%) 10 (34.5%) 1.00

Age
Years 54.7 ± 10.6 59.3 ± 13.3 0.15

Anthropometric Measures
Weight (lb) 201.1 ± 30.6 203.2 ± 50.9 0.84
Waist Circumference (cm) 107.2 ± 7.9 110.4 ± 15.8 0.41
BMI (kg/m2) 33.4 ± 6.1 32.7 ± 5.6 0.64

Metabolic Syndrome (1)
Yes 14 (46.7%) 19 (65.5%) 0.19

Blood Pressure
Systolic (mm Hg) 129.3 ± 12.3 129.6 ± 14.4 0.93
Diastolic (mm Hg) 75.6 ± 10.7 73.4 ± 12.5 0.79

Lab Values
Fasting Plasma Insulin (μU/ml) 15.6 ± 8.1 18.2 ± 11.6 0.33
2-hour OGTT Insulin (μU/ml) (3) 61.0 (18,226) 77.5 (14,483) 0.32
FPG (mg/dL) 103.8 ± 10.8 98.9 ± 9.0 0.06
2-hour OGTT Glucose (mg/dL) 131.8 ± 41.9 125.8 ± 30.0 0.53
HOMA-IR (2) 4.0 ± 2.0 4.4 ± 2.7 0.54
Whole blood HbA1c (%) 5.7 ± 0.4 5.7 ± 0.5 0.90
Serum total Cholesterol (mg/dL) 187.8 ± 26.5 185.0 ± 36.4 0.73
Serum HDL (mg/dL) 51.7 ± 11.6 45.0 ± 11.6 0.03
Serum LDL (mg/dL) 112.0 ± 26.5 116.2 ± 29.2 0.56
Serum Triglycerides (mg/dL) 120.1 ± 49.3 120.5 ± 48.2 0.98
Urine microalbumin (3) 5.6 (0.0, 90.1) 7.1 (0.0,57.8) 0.24
Serum creatinine (mg/dL) 0.9 ± 0.2 0.9 ± 0.2 0.53

Endothelial function
FMD Pre OGTT (% Δ) 7.8 ± 3.9 9.5 ± 4.7 0.15
FMD Pre OGTT Nitro (% Δ) 15.3 ± 5.7 16.2 ± 5.9 0.56
FMD Post OGTT (% Δ) 9.5 ± 4.5 10.2 ± 5.0 0.56
SARM Pre OGTT (4) 0.1 ± 0.1 0.1 ± 0.1 0.50
SARM Post OGTT (4) 0.1 ± 0.1 0.1 ± 0.1 0.42
1

Metabolic syndrome as defined by NCEP-ATP III criteria.

2

Homeostasis Model Assessment Insulin Resistance (HOMA-IR) by using the mathematical approximation, HOMA-IR = fasting plasma insulin (mU/mL) × fasting plasma glucose (mmol/L)/22.5.

3

Values are expressed as median (minimum, maximum).

4

SARM = stimulus-adjusted response measure.